ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,341.24
0.60%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Retrophin Inc (RTRX)

  7. Retrophin Inc (RTRX) Noticias

RTRX

Retrophin (RTRX)

Retrophin Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:RTRX
FechaHoraFuenteTítuloSímboloCompañía
31/05/202315:58Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTRXRetrophin Inc
19/05/202315:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RTRXRetrophin Inc
15/05/202316:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RTRXRetrophin Inc
10/05/202311:59Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:RTRXRetrophin Inc
04/05/202315:48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RTRXRetrophin Inc
13/04/202316:13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RTRXRetrophin Inc
23/02/202316:04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RTRXRetrophin Inc
06/02/202313:56Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RTRXRetrophin Inc
01/09/202217:19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:RTRXRetrophin Inc
18/08/202215:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:RTRXRetrophin Inc
17/08/202216:22Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:RTRXRetrophin Inc
09/03/202205:05Edgar (US Regulatory)Initial Statement of Trust Indenture (305b2)NASDAQ:RTRXRetrophin Inc
09/03/202205:04Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:RTRXRetrophin Inc
23/11/202113:58Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:RTRXRetrophin Inc
03/09/202115:21Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:RTRXRetrophin Inc
12/02/202116:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:RTRXRetrophin Inc
30/11/202015:05GlobeNewswire Inc.Travere Therapeutics Announces Completion of Patient Enrollment in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmen...NASDAQ:RTRXRetrophin Inc
16/11/202007:00GlobeNewswire Inc.Retrophin Announces Corporate Name Change to Travere Therapeutics, Inc.NASDAQ:RTRXRetrophin Inc
12/11/202015:05GlobeNewswire Inc.Retrophin Completes Acquisition of Orphan TechnologiesNASDAQ:RTRXRetrophin Inc
11/11/202015:30GlobeNewswire Inc.Retrophin to Present at Upcoming Investor ConferencesNASDAQ:RTRXRetrophin Inc
05/11/202015:01GlobeNewswire Inc.Retrophin Reports Third Quarter 2020 Financial ResultsNASDAQ:RTRXRetrophin Inc
22/10/202015:01GlobeNewswire Inc.Retrophin Announces Agreement to Acquire Orphan TechnologiesNASDAQ:RTRXRetrophin Inc
21/10/202015:30GlobeNewswire Inc.Retrophin to Report Third Quarter 2020 Financial ResultsNASDAQ:RTRXRetrophin Inc
14/10/202016:00GlobeNewswire Inc.Retrophin, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:RTRXRetrophin Inc
09/10/202015:01GlobeNewswire Inc.Retrophin Announces Presentation of Abstracts at ASN Kidney Week 2020 ReimaginedNASDAQ:RTRXRetrophin Inc
21/09/202007:00GlobeNewswire Inc.Retrophin Announces Enrollment of First 280 Patients in Pivotal Phase 3 PROTECT Study of Sparsentan in IgA NephropathyNASDAQ:RTRXRetrophin Inc
30/07/202015:01GlobeNewswire Inc.Retrophin Reports Second Quarter 2020 Financial ResultsNASDAQ:RTRXRetrophin Inc
16/07/202015:30GlobeNewswire Inc.Retrophin to Report Second Quarter 2020 Financial ResultsNASDAQ:RTRXRetrophin Inc
19/06/202007:00GlobeNewswire Inc.Retrophin to Present at the BMO 2020 Prescriptions for Success Healthcare ConferenceNASDAQ:RTRXRetrophin Inc
08/06/202021:02GlobeNewswire Inc.Retrophin Announces Pricing of Public Offering of Common StockNASDAQ:RTRXRetrophin Inc
 Showing the most relevant articles for your search:NASDAQ:RTRX

Su Consulta Reciente

LSE
70NN
Toy.mf.n. 23
USOTC
SFIN
Safetek (CE)
NASDAQ
ARTLP
NASDAQ
FQOWZX
Covered Call Select Clos...
LSE
DY87
Tor.dom.25 S
BMF
CIELRK24M24
CIELRK24M24 - 05/2024
MRTX
BIRDBTC
BirdCoin
NASDAQ
LGHLW
Lion
NASDAQ
ABAFTXX
Morgan Stanley Finance L...
LSE
RE57
Atlas 2022-1 60
NYSE
HGLB
Highland Global Allocation
LSE
BIEB
Birse
NASDAQ
FHJGRX
Stifel Best Picks Januar...
LSE
38GK
Municplty 36
USOTC
FKRAF
Fishkars (PK)
BOV
BIVE39
BlackRock Institutional ...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados